KARYOPHARM THERAPEUTICS INC (KPTI) Stock Income Statement
NASDAQ:KPTI - Nasdaq - US48576U2050 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 145.24M | 146.03M | 157.10M | 209.80M | 108.10M | |||
| Cost Of Goods | 6.01M | 4.94M | 5.20M | 3.40M | 2.70M | |||
| Gross Profit | 139.23M | 141.09M | 151.90M | 206.40M | 105.40M | |||
| Operating Expenses | 258.67M | 270.63M | 294.10M | 304.70M | 277.20M | |||
| Research and Development | 143.23M | 138.75M | 148.70M | 160.80M | 150.80M | |||
| Selling, General, and Administrative Expenses | 115.44M | 131.88M | 145.40M | 143.80M | 126.40M | |||
| Operating Income | -119.44M | -129.54M | -142.20M | -98.30M | -171.90M | |||
| Interest Income/Expense | -30.02M | -12.88M | -22.60M | -25.50M | -24.30M | |||
| Other Income/Expense | 28.40M | -356.00K | -100.00K | -100.00K | 200.00K | |||
| Non Recurring Items | 44.70M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -76.36M | -142.78M | -164.90M | -123.80M | -196.00M | |||
| Income Tax | 57.00K | 323.00K | 400.00K | 300.00K | 300.00K | |||
| Net Income | -76.42M | -143.10M | -165.30M | -124.10M | -196.30M | |||
| EBITDA | -119.10M | -129.01M | -141.58M | -97.51M | -170.93M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -9.41 | -18.79 | -30.28 | -24.74 | -40.86 | |||
| Non GAAP EPS | -10.05 | -18.75 | -30.45 | -25.65 | -40.95 | |||
| Statistics | ||||||||
| Gross Profit Margin | 95.86% | 96.62% | 96.69% | 98.38% | 97.50% | |||
| Profit Margin | -52.62% | -97.99% | -105.22% | -59.15% | -181.59% | |||
| Operating Profit Margin | -82.24% | -88.71% | -90.52% | -46.85% | -159.02% | |||
All data in USD